101
|
Ford BD, Han B, Fischbach GD. Differentiation-dependent regulation of skeletal myogenesis by neuregulin-1. Biochem Biophys Res Commun 2003; 306:276-81. [PMID: 12788100 DOI: 10.1016/s0006-291x(03)00964-1] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Neuregulins comprise a group of growth factor proteins that regulate the differentiation of skeletal muscle. Here, we report that neuregulins are regulators of myogenic differentiation and stimulate mitogenesis in L6 skeletal myoblasts. The mitogenic response to neuregulin-1 was differentiation-dependent and observed only in aligned, differentiating cells. Treatment of these cells with neuregulin-1 increased [3H]thymidine incorporation and cell proliferation by 2- to 5-fold, while a minimal increase was seen in proliferating myoblasts. Neuregulin-1 did not induce DNA synthesis in fused, multinucleated myotubes. The increased DNA synthesis correlated with downregulation of myogenin and inhibition of myoblast fusion and myotube formation. These data suggest that neuregulins may regulate skeletal myogenesis in vivo and that this regulation is dependent on the state of differentiation of the myocytes.
Collapse
Affiliation(s)
- Byron D Ford
- Department of Anatomy and Neurobiology, Morehouse School of Medicine, 720 Westview Drive, SW, Atlanta, GA 30310, USA.
| | | | | |
Collapse
|
102
|
Rosen KM, Ford BD, Querfurth HW. Downregulation and increased turnover of beta-amyloid precursor protein in skeletal muscle cultures by neuregulin-1. Exp Neurol 2003; 181:170-80. [PMID: 12781990 DOI: 10.1016/s0014-4886(03)00031-1] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The beta-amyloid precursor protein (betaAPP) is found in skeletal muscle localized to the base of the postsynaptic folds of the neuromuscular junction; yet here, as well as in neurons, its function remains enigmatic. Here we report that the motor nerve-derived trophic factor neuregulin-1 (NRG1) regulates both steady-state betaAPP levels as well as the metabolism of the cell surface-associated protein in cultured muscle cells. These two effects occur over two discernible time scales. At short times (minutes to hours), NRG1 increases the rate of internalization and apparent degradation of cell surface betaAPP while reducing the release of soluble APP to the medium. At longer times (hours to days), NRG1 causes a decrease in mRNA for betaAPP with a concomitant reduction in steady-state protein levels. These are novel findings for this trophic factor originally identified as inducing the expression of nicotinic acetylcholine receptors and other important synaptic proteins in skeletal muscle. They suggest that betaAPP may play a receptor or signal transduction role at the neuromuscular junction since other receptor protein's actions are terminated in a similar fashion. The effects of NRG1 on betaAPP metabolism are overcome by inhibitors of both the phosphatidylinositol-3 (PI3) kinase and mitogen-activated protein (MAP) kinase pathways, yet are distinct from those activated during induction of nicotinic acetylcholine receptor biosynthesis. BetaAPP should be added to the list of specialized post-neuromuscular junction proteins that are regulated by cholinergic terminal-derived factors critical to synaptogenesis.
Collapse
Affiliation(s)
- Kenneth M Rosen
- Division of Neurology, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA.
| | | | | |
Collapse
|
103
|
Abstract
Neuregulin (NRG) regulates synapse formation and synaptic plasticity, but little is known about the regulation of NRG signaling at synapses. Here we show that the NRG receptor ErbB4 was localized in anatomically defined postsynaptic densities in the brain. In cultured cortical neurons, ErbB4 was recruited to the neuronal lipid raft fraction after stimulation by NRG. Along with ErbB4, adaptor proteins Grb2 and Shc were translocated to lipid rafts by NRG stimulation. In transfected human embryonic kidney 293 cells, the partitioning of ErbB4 into a detergent-insoluble fraction that includes lipid rafts was increased by PSD-95 (postsynaptic density-95), through interaction of the ErbB4 C terminus with the PDZ [PSD-95/Discs large/zona occludens-1] domains of PSD-95. Disruption of lipid rafts inhibited NRG-induced activation of Erk and prevented NRG-induced blockade of induction of long-term potentiation at hippocampal CA1 synapses. Thus, our results indicate that NRG stimulation causes translocation of ErbB4 into lipid rafts and that lipid rafts are necessary for signaling by ErbB4.
Collapse
|
104
|
Lacazette E, Le Calvez S, Gajendran N, Brenner HR. A novel pathway for MuSK to induce key genes in neuromuscular synapse formation. J Cell Biol 2003; 161:727-36. [PMID: 12756238 PMCID: PMC2199368 DOI: 10.1083/jcb.200210156] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
At the developing neuromuscular junction the Agrin receptor MuSK is the central organizer of subsynaptic differentiation induced by Agrin from the nerve. The expression of musk itself is also regulated by the nerve, but the mechanisms involved are not known. Here, we analyzed the activation of a musk promoter reporter construct in muscle fibers in vivo and in cultured myotubes, using transfection of multiple combinations of expression vectors for potential signaling components. We show that neuronal Agrin by activating MuSK regulates the expression of musk via two pathways: the Agrin-induced assembly of muscle-derived neuregulin (NRG)-1/ErbB, the pathway thought to regulate acetylcholine receptor (AChR) expression at the synapse, and via a direct shunt involving Agrin-induced activation of Rac. Both pathways converge onto the same regulatory element in the musk promoter that is also thought to confer synapse-specific expression to AChR subunit genes. In this way, a positive feedback signaling loop is established that maintains musk expression at the synapse when impulse transmission becomes functional. The same pathways are used to regulate synaptic expression of AChR epsilon. We propose that the novel pathway stabilizes the synapse early in development, whereas the NRG/ErbB pathway supports maintenance of the mature synapse.
Collapse
Affiliation(s)
- Eric Lacazette
- Department of Physiology, University of Basel, CH-4056 Basel, Switzerland
| | | | | | | |
Collapse
|
105
|
Barnard EA, Simon J, Tsim KW, Filippov AK, Brown DA. Signalling pathways and ion channel regulations of P2Y receptors. Drug Dev Res 2003. [DOI: 10.1002/ddr.10200] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
106
|
Kang BH, Jo I, Eun SY, Jo SA. Cyclic AMP-dependent protein kinase A and CREB are involved in neuregulin-induced synapse-specific expression of acetylcholine receptor gene. Biochem Biophys Res Commun 2003; 304:758-65. [PMID: 12727221 DOI: 10.1016/s0006-291x(03)00660-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Neuregulin is reported to stimulate synapse-specific transcription of acetylcholine receptor (AChR) genes in the skeletal muscle fiber by multiple signaling pathways such as ERK, PI3K, and JNK. The co-localization of PKA mRNA with AChR and ErbBs, receptors for neuregulin, at the confined region of synapse implicates the putative role of PKA in neuregulin-induced AChR gene expression. In the present study, we found that mRNA and protein of a regulatory subunit of PKA (PKARIalpha) were concentrated at synaptic sites of the rat sternomastoid muscle fiber, while those of ERK and PI3K were uniformly distributed throughout the muscle fiber. Neuregulin (100 ng/ml) increased both PKA activity in the nucleus and AChRdelta subunit gene transcription in cultured Sol8 myotubes. These increases were significantly blocked by a specific PKA inhibitor H-89 (100 nM) and an adenylcyclase inhibitor SQ 22536 (200 microM) (72.5% and 60.1%, respectively). Furthermore, neuregulin phosphorylated CREB, a well-known down-stream transcription factor of PKA. While H-89 inhibited CREB phosphorylation, H-89 and PD098059 (50 microM), a specific MEK1/2 inhibitor, did not inhibit the phosphorylation of ERK and CREB, respectively, suggesting no cross-talk between PKA and ERK pathways. In conclusion, neuregulin increases AChRdelta subunit gene transcription, in part, by the activation of PKA/CREB, an alternative route to the previously reported ERK signaling pathway.
Collapse
Affiliation(s)
- Byung-Hak Kang
- Department of Biomedical Sciences, National Institute of Health, 5 Nokbun-dong, Eunpyung-gu, Seoul 122-701, South Korea
| | | | | | | |
Collapse
|
107
|
Chakkalakal JV, Jasmin BJ. Localizing synaptic mRNAs at the neuromuscular junction: it takes more than transcription. Bioessays 2003; 25:25-31. [PMID: 12508279 DOI: 10.1002/bies.10205] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The neuromuscular junction has been used for several decades as an excellent model system to examine the cellular and molecular events involved in the formation and maintenance of a differentiated chemical synapse. In this context, several laboratories have focused their efforts over the last 15 years on the important contribution of transcriptional mechanisms to the regulation of the development and plasticity of the postsynaptic apparatus in muscle fibers. Converging lines of evidence now indicate that post-transcriptional events, operating at the level of mRNA stability and targeting, are likely to also play key roles at the neuromuscular junction. Here, we present the recent findings highlighting the role of these additional molecular events and extend our review to include data showing that post-transcriptional events are also important in the control of the expression of genes encoding synaptic proteins in muscle cells placed under different conditions. Finally, we discuss the possibility that mis-regulation of post-transcriptional events can occur in certain neuromuscular diseases and cause abnormalities of the neuromuscular junction.
Collapse
Affiliation(s)
- Joe V Chakkalakal
- Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ontario, Canada
| | | |
Collapse
|
108
|
Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, Gunnarsdottir S, Walker N, Petursson H, Crombie C, Ingason A, Gulcher JR, Stefansson K, Clair DS. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003; 72:83-7. [PMID: 12478479 PMCID: PMC420015 DOI: 10.1086/345442] [Citation(s) in RCA: 415] [Impact Index Per Article: 19.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2002] [Accepted: 10/03/2002] [Indexed: 11/03/2022] Open
Abstract
Recently, we identified neuregulin 1 (NRG1) as a susceptibility gene for schizophrenia in the Icelandic population, by a combined linkage and association approach. Here, we report the first study evaluating the relevance of NRG1 to schizophrenia in a population outside Iceland. Markers representing a core at-risk haplotype found in Icelanders at the 5' end of the NRG1 gene were genotyped in 609 unrelated Scottish patients and 618 unrelated Scottish control individuals. This haplotype consisted of five SNP markers and two microsatellites, which all appear to be in strong linkage disequilibrium. For the Scottish patients and control subjects, haplotype frequencies were estimated by maximum likelihood, using the expectation-maximization algorithm. The frequency of the seven-marker haplotype among the Scottish patients was significantly greater than that among the control subjects (10.2% vs. 5.9%, P=.00031). The estimated risk ratio was 1.8, which is in keeping with our report of unrelated Icelandic patients (2.1). Three of the seven markers in the haplotype gave single-point P values ranging from .000064 to .0021 for the allele contributing to the at-risk haplotype. This direct replication of haplotype association in a second population further implicates NRG1 as a factor that contributes to the etiology of schizophrenia.
Collapse
Affiliation(s)
- Hreinn Stefansson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| | - Jane Sarginson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| | - Augustine Kong
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| | - Phil Yates
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| | - Valgerdur Steinthorsdottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| | - Einar Gudfinnsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| | - Steinunn Gunnarsdottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| | - Nicholas Walker
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| | - Hannes Petursson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| | - Caroline Crombie
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| | - Andres Ingason
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| | - Jeffrey R. Gulcher
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| | - Kari Stefansson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| | - David St Clair
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Aberdeen Royal Infirmary and University of Aberdeen Medical School, Aberdeen; and Ravenscraig Hospital, Greenock, Scotland
| |
Collapse
|
109
|
Chaudhury AR, Gerecke KM, Wyss JM, Morgan DG, Gordon MN, Carroll SL. Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J Neuropathol Exp Neurol 2003; 62:42-54. [PMID: 12528817 DOI: 10.1093/jnen/62.1.42] [Citation(s) in RCA: 90] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Neuregulin-1 (NRG-1) regulates developmental neuronal survival and synaptogenesis, astrocytic differentiation, and microglial activation. Given these NRG-1 actions, we hypothesized that the synaptic loss, gliosis, inflammation, and neuronal death occurring in Alzheimer disease (AD) is associated with altered expression of NRG-1 and its receptors (the erbB2, erbB3, and erbB4 membrane tyrosine kinases). We examined the expression and distribution of NRG-1 and the erbB kinases in the hippocampus of AD patients and cognitively normal controls and in transgenic mice that coexpress AD-associated mutations of the beta amyloid precursor protein (APP(K670N,M671L)) and presenilin-1 (PS1(M146L)). In the hippocampi of both control humans and wild type mice, NRG-1 and the 3 erbB receptors are expressed in distinct cellular compartments of hippocampal neurons. All 4 molecules are associated with neuronal cell bodies, but only NRG-1, erbB2, and erbB4 are present in synapse-rich regions. In AD and in the doubly transgenic mouse, erbB4 is expressed by reactive astrocytes and microglia surrounding neuritic plaques. In AD brains, microglia and, to a lesser extent, dystrophic neurites, also upregulate NRG-1 in neuritic plaques, suggesting that autocrine and/or paracrine interactions regulate NRG-1 action within these lesions. NRG-1 and erbB4, as well as erbB2, are similarly associated with neuritic plaques in the doubly transgenic mice. Thus, in AD the hippocampal distribution of NRG-1 and erbB4 is altered. The similarities between the alterations in the expression of NRG-1 and its receptors in human AD and in APP(K670N;M671L)/PS1(M146L) mutant mice suggests that this animal model may be very informative in deciphering the potential role of these molecules in AD.
Collapse
Affiliation(s)
- Abhik Ray Chaudhury
- Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama 35294-0017, USA
| | | | | | | | | | | |
Collapse
|
110
|
Hippenmeyer S, Shneider NA, Birchmeier C, Burden SJ, Jessell TM, Arber S. A role for neuregulin1 signaling in muscle spindle differentiation. Neuron 2002; 36:1035-49. [PMID: 12495620 DOI: 10.1016/s0896-6273(02)01101-7] [Citation(s) in RCA: 121] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
The maturation of synaptic structures depends on inductive interactions between axons and their prospective targets. One example of such an interaction is the influence of proprioceptive sensory axons on the differentiation of muscle spindles. We have monitored the expression of three transcription factors, Egr3, Pea3, and Erm, that delineate early muscle spindle development in an assay of muscle spindle-inducing signals. We provide genetic evidence that Neuregulin1 (Nrg1) is required for proprioceptive afferent-evoked induction of muscle spindle differentiation in the mouse. Ig-Nrg1 isoforms are preferentially expressed by proprioceptive sensory neurons and are sufficient to induce muscle spindle differentiation in vivo, whereas CRD-Nrg1 isoforms are broadly expressed in sensory and motor neurons but are not required for muscle spindle induction.
Collapse
MESH Headings
- Animals
- Cell Differentiation/genetics
- DNA-Binding Proteins/genetics
- DNA-Binding Proteins/metabolism
- Early Growth Response Protein 3
- Female
- Fetus
- Ganglia, Spinal/cytology
- Ganglia, Spinal/embryology
- Ganglia, Spinal/metabolism
- Gene Expression Regulation, Developmental/genetics
- Male
- Mice
- Mice, Knockout
- Motor Neurons/cytology
- Motor Neurons/metabolism
- Muscle Spindles/cytology
- Muscle Spindles/embryology
- Muscle Spindles/metabolism
- Muscle, Skeletal/cytology
- Muscle, Skeletal/embryology
- Muscle, Skeletal/innervation
- Mutation/genetics
- Neuregulin-1/deficiency
- Neuregulin-1/genetics
- Neurons, Afferent/cytology
- Neurons, Afferent/metabolism
- Proprioception/genetics
- Protein Isoforms/genetics
- Protein Isoforms/metabolism
- Signal Transduction/genetics
- Transcription Factors/genetics
- Transcription Factors/metabolism
Collapse
Affiliation(s)
- Simon Hippenmeyer
- Biozentrum, Department of Cell Biology, University of Basel, Klingelbergstrasse 70, 4056-, Basel, Switzerland
| | | | | | | | | | | |
Collapse
|
111
|
Abstract
Upregulation of neuregulin has been demonstrated in traumatic brain injury, but a role for neuregulin in ischemic brain injury has not been investigated. Therefore, we used a rat permanent middle cerebral artery occlusion model to examine the distribution of neuregulin after the onset of ischemic stroke. We found an increase in immunohistochemical staining for neuregulin in the penumbral regions of the cortex. The increase in neuregulin appeared to be neuronal. There was no neuregulin co-localization with astrocytes or macrophages. These results demonstrate that neuregulin is induced in neurons following ischemic stroke and may be involved in neuroprotection and repair.
Collapse
|
112
|
Affiliation(s)
- Steven J Burden
- Molecular Neurobiology Program, Skirball Institute, NYU Medical School, 540 First Avenue, New York City, New York 10016, USA.
| |
Collapse
|
113
|
Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71:877-92. [PMID: 12145742 PMCID: PMC378543 DOI: 10.1086/342734] [Citation(s) in RCA: 1169] [Impact Index Per Article: 53.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2002] [Accepted: 07/09/2002] [Indexed: 01/08/2023] Open
Abstract
The cause of schizophrenia is unknown, but it has a significant genetic component. Pharmacologic studies, studies of gene expression in man, and studies of mouse mutants suggest involvement of glutamate and dopamine neurotransmitter systems. However, so far, strong association has not been found between schizophrenia and variants of the genes encoding components of these systems. Here, we report the results of a genomewide scan of schizophrenia families in Iceland; these results support previous work, done in five populations, showing that schizophrenia maps to chromosome 8p. Extensive fine-mapping of the 8p locus and haplotype-association analysis, supplemented by a transmission/disequilibrium test, identifies neuregulin 1 (NRG1) as a candidate gene for schizophrenia. NRG1 is expressed at central nervous system synapses and has a clear role in the expression and activation of neurotransmitter receptors, including glutamate receptors. Mutant mice heterozygous for either NRG1 or its receptor, ErbB4, show a behavioral phenotype that overlaps with mouse models for schizophrenia. Furthermore, NRG1 hypomorphs have fewer functional NMDA receptors than wild-type mice. We also demonstrate that the behavioral phenotypes of the NRG1 hypomorphs are partially reversible with clozapine, an atypical antipsychotic drug used to treat schizophrenia.
Collapse
Affiliation(s)
- Hreinn Stefansson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Engilbert Sigurdsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Valgerdur Steinthorsdottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Soley Bjornsdottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Thordur Sigmundsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Shyamali Ghosh
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Jon Brynjolfsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Steinunn Gunnarsdottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Omar Ivarsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Thomas T. Chou
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Omar Hjaltason
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Birgitta Birgisdottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Helgi Jonsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Vala G. Gudnadottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Elsa Gudmundsdottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Asgeir Bjornsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Brynjolfur Ingvarsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Andres Ingason
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Sigmundur Sigfusson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Hronn Hardardottir
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Richard P. Harvey
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Donna Lai
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Mingdong Zhou
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Daniela Brunner
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Vincent Mutel
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Acuna Gonzalo
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Greg Lemke
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Jesus Sainz
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Gardar Johannesson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Thorkell Andresson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Daniel Gudbjartsson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Andrei Manolescu
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Michael L. Frigge
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Mark E. Gurney
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Augustine Kong
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Jeffrey R. Gulcher
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Hannes Petursson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| | - Kari Stefansson
- deCODE Genetics and Department of Psychiatry, National University Hospital, Reykjavík; Department of Psychiatry, Akureyri Hospital, Akureyri, Iceland; Victor Chang Cardiac Research Institute and Faculties of Medicine and Life Sciences, University of New South Wales, Sydney; Zensun Sci & Tech, Shanghai; PsychoGenics, New York; F. Hoffmann–La Roche, Basel, Switzerland; and Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, CA
| |
Collapse
|
114
|
Fried K, Risling M, Tidcombe H, Gassmann M, Lillesaar C. Expression of ErbB3, ErbB4, and neuregulin-1 mRNA during tooth development. Dev Dyn 2002; 224:356-60. [PMID: 12112465 DOI: 10.1002/dvdy.10114] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
The receptor tyrosine kinases ErbB3 and ErbB4, which bind to various variants of neuregulin (NRG), play fundamental roles in neural development and in organs, which form through epithelial-mesenchymal interactions. Here, we demonstrate that NRG-1 and the receptors ErbB3 and ErbB4 are expressed locally during rodent tooth development. However, the mRNA expression patterns of ErbB3 and ErbB4 were distinctly different during odontogenesis. Examinations of teeth in genetically heart-rescued ErbB4-/- mice did not reveal any obvious deviation from the normal phenotype. The results suggest that ErbB3 and ErbB4 may participate in tooth morphogenesis. The specific interactions between NRG isoforms and ErbB receptors during this process remain to be determined.
Collapse
Affiliation(s)
- K Fried
- Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
| | | | | | | | | |
Collapse
|
115
|
Huang YZ, Wang Q, Won S, Luo ZG, Xiong WC, Mei L. Compartmentalized NRG signaling and PDZ domain-containing proteins in synapse structure and function. Int J Dev Neurosci 2002; 20:173-85. [PMID: 12175853 DOI: 10.1016/s0736-5748(02)00011-4] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Abstract
The synapse-specific synthesis of the acetylcholine receptor (AChR) is mediated by multiple mechanisms including compartmentalized signaling induced by neuregulin (NRG). This paper presents evidence that NRG receptors--ErbB receptor tyrosine kinases interact with distinct PDZ domain-containing proteins that are localized at the neuromuscular junction (NMJ). ErbB4 associates with the PSD-95 (also known as SAP90)-family members including PSD-95, SAP97, and SAP102 whereas ErbB2 interacts with Erbin and PICK1. Although, ErbB kinases are concentrated at the NMJ, they are not colocalized with the AChR in cultured muscle cells even in the presence of agrin. Co-expression of PSD-95 causes ErbB4 to form clusters in COS cells. We propose that PDZ domain-containing proteins play a role in anchoring ErbB proteins at the neuromuscular junction, and/or mediating downstream signaling pathways. Such mechanisms could be important for the maintenance and function of the synapse.
Collapse
Affiliation(s)
- Yang Z Huang
- Department of Neurobiology, Pathology, Physical Medicine and Rehabilitation, University of Alabama at Birmingham, 35294-0021, USA
| | | | | | | | | | | |
Collapse
|
116
|
Gyrd-Hansen M, Krag TOB, Rosmarin AG, Khurana TS. Sp1 and the ets-related transcription factor complex GABP alpha/beta functionally cooperate to activate the utrophin promoter. J Neurol Sci 2002; 197:27-35. [PMID: 11997063 DOI: 10.1016/s0022-510x(02)00038-2] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Duchenne muscular dystrophy (DMD) is a fatal neuromuscular disease caused by the absence of dystrophin. Utrophin is the autosomal homolog of dystrophin and capable of compensating for the absence of dystrophin, when overexpressed. In skeletal muscle, utrophin plays an important role in the formation of neuromuscular junctions. This selective enrichment occurs, in part by transcriptional regulation of the utrophin gene at the sub-synaptic nuclei in muscle. Utrophin's complex transcriptional regulation is not yet fully understood, however, GABP alpha / beta has recently been shown to bind the N box and activate the utrophin promoter in response to heregulin. In this study, we show that the transcription factor Sp1 binds and activates the utrophin promoter in Drosophila S2 cells as well as define a Sp1 response element. We demonstrate that heregulin treatment of cultured muscle cells activates the ERK pathway and phosphorylates serine residue(s) in the consensus ERK recognition site of Sp1. Finally, Sp1 is shown to functionally cooperate with GABP alpha / beta and cause a 58-fold increase of de novo utrophin promoter transcription. Taken together, these findings help define mechanisms used for transcriptional regulation of utrophin expression as well as identify new targets for achieving potentially therapeutic upregulation of utrophin in DMD.
Collapse
Affiliation(s)
- Mads Gyrd-Hansen
- Department of Clinical Biochemistry, Glostrup Hospital, University of Copenhagen, Glostrup, Denmark
| | | | | | | |
Collapse
|
117
|
Neuregulin expression at neuromuscular synapses is modulated by synaptic activity and neurotrophic factors. J Neurosci 2002. [PMID: 11896160 DOI: 10.1523/jneurosci.22-06-02206.2002] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
The proper formation of neuromuscular synapses requires ongoing synaptic activity that is translated into complex structural changes to produce functional synapses. One mechanism by which activity could be converted into these structural changes is through the regulated expression of specific synaptic regulatory factors. Here we demonstrate that blocking synaptic activity with curare reduces synaptic neuregulin expression in a dose-dependent manner yet has little effect on synaptic agrin or a muscle-derived heparan sulfate proteoglycan. These changes are associated with a fourfold increase in number and a twofold reduction in average size of synaptic acetylcholine receptor clusters that appears to be caused by excessive axonal sprouting with the formation of new, smaller acetylcholine receptor clusters. Activity blockade also leads to threefold reductions in brain-derived neurotrophic factor and neurotrophin 3 expression in muscle without appreciably changing the expression of these same factors in spinal cord. Adding back these or other neurotrophic factors restores synaptic neuregulin expression and maintains normal end plate band architecture in the presence of activity blockade. The expression of neuregulin protein at synapses is independent of spinal cord and muscle neuregulin mRNA levels, suggesting that neuregulin accumulation at synapses is independent of transcription. These findings suggest a local, positive feedback loop between synaptic regulatory factors that translates activity into structural changes at neuromuscular synapses.
Collapse
|
118
|
Huh KH, Fuhrer C. Clustering of nicotinic acetylcholine receptors: from the neuromuscular junction to interneuronal synapses. Mol Neurobiol 2002; 25:79-112. [PMID: 11890459 DOI: 10.1385/mn:25:1:079] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Fast and accurate synaptic transmission requires high-density accumulation of neurotransmitter receptors in the postsynaptic membrane. During development of the neuromuscular junction, clustering of acetylcholine receptors (AChR) is one of the first signs of postsynaptic specialization and is induced by nerve-released agrin. Recent studies have revealed that different mechanisms regulate assembly vs stabilization of AChR clusters and of the postsynaptic apparatus. MuSK, a receptor tyrosine kinase and component of the agrin receptor, and rapsyn, an AChR-associated anchoring protein, play crucial roles in the postsynaptic assembly. Once formed, AChR clusters and the postsynaptic membrane are stabilized by components of the dystrophin/utrophin glycoprotein complex, some of which also direct aspects of synaptic maturation such as formation of postjunctional folds. Nicotinic receptors are also expressed across the peripheral and central nervous system (PNS/CNS). These receptors are localized not only at the pre- but also at the postsynaptic sites where they carry out major synaptic transmission. In neurons, they are found as clusters at synaptic or extrasynaptic sites, suggesting that different mechanisms might underlie this specific localization of nicotinic receptors. This review summarizes the current knowledge about formation and stabilization of the postsynaptic apparatus at the neuromuscular junction and extends this to explore the synaptic structures of interneuronal cholinergic synapses.
Collapse
Affiliation(s)
- Kyung-Hye Huh
- Department of Neurochemistry, Brain Research Institute, University of Zürich, Switzerland
| | | |
Collapse
|
119
|
Meunier FA, Schiavo G, Molgó J. Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. JOURNAL OF PHYSIOLOGY, PARIS 2002; 96:105-13. [PMID: 11755789 DOI: 10.1016/s0928-4257(01)00086-9] [Citation(s) in RCA: 137] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The neuromuscular junction is one of the most accessible mammalian synapses which offers a useful model to study long-term synaptic modifications occurring throughout life. It is also the natural target of botulinum neurotoxins (BoNTs) causing a selective blockade of the regulated exocytosis of acetylcholine thereby triggering a profound albeit transitory muscular paralysis. The scope of this review is to describe the principal steps implicated in botulinum toxin intoxication from the early events leading to a paralysis to the cellular response implementing an impressive synaptic remodelling culminating in the functional recovery of neuromuscular transmission. BoNT/A treatment promotes extensive sprouting emanating from intoxicated motor nerve terminals and the distal portion of motor axons. The current view is that sprouts have the ability to form functional synapses as they display a number of key proteins required for exocytosis: SNAP-25, VAMP/synaptobrevin, syntaxin-I, synaptotagmin-II, synaptophysin, and voltage-activated Na+, Ca2+ and Ca2+-activated K+ channels. Exo-endocytosis was demonstrated (using the styryl dye FM1-43) to occur only in the sprouts in vivo, at the time of functional recovery emphasising the direct role of nerve terminal outgrowth in implementing the restoration of functional neurotransmitter release (at a time when nerve stimulation again elicited muscle contraction). Interestingly, sprouts are only transitory since a second distinct phase of the rehabilitation process occurs with a return of synaptic activity to the original nerve terminals. This is accompanied by the elimination of the dispensable sprouts. The growth or elimination of these nerve processes appears to be strongly correlated with the level of synaptic activity at the parent terminal. The BoNT/A-induced extension and later removal of "functional" sprouts indicate their fundamental importance in the rehabilitation of paralysed endplates, a finding with ramifications for the vital process of nerve regeneration.
Collapse
Affiliation(s)
- Frédéric A Meunier
- Molecular NeuroPathobiology Laboratory, Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London WC2A 3PX, UK.
| | | | | |
Collapse
|
120
|
Moore C, Leu M, Müller U, Brenner HR. Induction of multiple signaling loops by MuSK during neuromuscular synapse formation. Proc Natl Acad Sci U S A 2001; 98:14655-60. [PMID: 11717400 PMCID: PMC64737 DOI: 10.1073/pnas.251291598] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2001] [Indexed: 11/18/2022] Open
Abstract
At the neuromuscular junction, two motor neuron-derived signals have been implicated in the regulation of synaptogenesis. Neuregulin-1 is thought to induce transcription of acetylcholine receptor (AChR) genes in subsynaptic muscle nuclei by activating ErbB receptors. Neural agrin aggregates AChRs by activating the receptor tyrosine kinase MuSK. Here, we show that these two signals act sequentially. Agrin, by activating MuSK, induces the synthesis and aggregation of both MuSK and ErbB receptors. ErbB acts downstream of MuSK in synapse formation. In this way, MuSK activation leads to the establishment of a neuregulin-1-dependent signaling complex that maintains MuSK, ErbB, and AChR expression at the synapse of electrically active muscle fibers.
Collapse
Affiliation(s)
- C Moore
- Department of Physiology, University of Basel, 4051 Basel, Switzerland
| | | | | | | |
Collapse
|
121
|
Sodium channel mRNAs at the neuromuscular junction: distinct patterns of accumulation and effects of muscle activity. J Neurosci 2001. [PMID: 11606634 DOI: 10.1523/jneurosci.21-21-08456.2001] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Voltage-gated sodium channels (VGSCs) are highly concentrated at the neuromuscular junction (NMJ) in mammalian skeletal muscle. Here we test the hypothesis that local upregulation of mRNA contributes to this accumulation. We designed radiolabeled antisense RNA probes, specific for the "adult" Na(V)1.4 and "fetal" Na(V)1.5 isoforms of VGSC in mammalian skeletal muscle, and used them in in situ hybridization studies of rat soleus muscles. Na(V)1.4 mRNA is present throughout normal adult muscles but is highly concentrated at the NMJ, in which the amount per myonucleus is more than eightfold greater than away from the NMJ. Na(V)1.5 mRNA is undetectable in innervated muscles but is dramatically upregulated by denervation. In muscles denervated for 1 week, both Na(V)1.4 and Na(V)1.5 mRNAs are present throughout the muscle, and both are concentrated at the NMJ. No Na(V)1.5 mRNA was detectable in denervated muscles stimulated electrically for 1 week in vivo. Neither denervation nor stimulation had any significant effect on the level or distribution of Na(V)1.4 mRNA. We conclude that factors, probably derived from the nerve, lead to the increased concentration of VGSC mRNAs at the NMJ. In addition, the expression of Na(V)1.5 mRNA is downregulated by muscle activity, both at the NMJ and away from it.
Collapse
|
122
|
Sanes JR, Lichtman JW. Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat Rev Neurosci 2001; 2:791-805. [PMID: 11715056 DOI: 10.1038/35097557] [Citation(s) in RCA: 753] [Impact Index Per Article: 32.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- J R Sanes
- Department of Anatomy and Neurobiology, Washington University School of Medicine, 660 South Euclid, Campus Box 8108, St Louis, Missouri 63110-1093, USA.
| | | |
Collapse
|
123
|
Blottner D, Lück G. Just in time and place: NOS/NO system assembly in neuromuscular junction formation. Microsc Res Tech 2001; 55:171-80. [PMID: 11747092 DOI: 10.1002/jemt.1168] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Recent advances in the molecular, biochemical, and anatomical aspects of postsynaptic membrane components at the neuromuscular junction (NMJ) are briefly reviewed focussing on assembly, architecture, and function of the multi-subunit dystrophin-protein complex (DPC) and its associated nitric oxide (NO)-signaling complex. Elucidation of unique structural binding motifs of NO-synthases (NOS), and microscopical codistribution of neuronal NOS (nNOS), the major isoform of NOS expressed at the NMJ, with known synaptic proteins, i.e., family members of the DPC, nicotinic acetylcholine receptor (AChR), NMDA-receptor, type-1 sodium and Shaker K(+)-channel proteins, and linker proteins (e.g., PSD-95, 43K-rapsyn), suggests targeting and assembly of the NO-signaling pathway at postsynaptic membrane components. NO mediates agrin-induced AChR-aggregation and downstream signal transduction in C2 skeletal myotubes while administration of L-arginine, the limiting substrate for NO-biosynthesis, enhances aggregation of synapse-specific components such as utrophin. At the NMJ, NO appears to be a mediator of (1) early synaptic protein clustering, (2) synaptic receptor activity and transmitter release, or (3) downstream signaling for transcriptional control. Multidisciplinary data obtained from cellular and molecular studies and from immunolocalization investigations have led us to propose a working model for step-by-step binding of nNOS, e.g., to subunit domains of targeted and/or preexisting membrane components. Formation of NOS-membrane complexes appears to be governed by agrin-signaling as well as by NO-signaling, supporting the idea that parallel signaling pathways may account for the spatiotemporally defined postsynaptic assembly thereby linking the NOS/NO-signaling cascade to early membrane aggregations and at the right places nearby preexisting targets (e.g., juxtaposition of NO source and target) in synapse formation.
Collapse
Affiliation(s)
- D Blottner
- Department of Anatomy 1, Neurobiology Group, Freie Universität Berlin, Königin-Luise-Strasse 15, D-14195 Berlin-Dahlem, Germany.
| | | |
Collapse
|
124
|
Hansen MR, Vijapurkar U, Koland JG, Green SH. Reciprocal signaling between spiral ganglion neurons and Schwann cells involves neuregulin and neurotrophins. Hear Res 2001; 161:87-98. [PMID: 11744285 DOI: 10.1016/s0378-5955(01)00360-4] [Citation(s) in RCA: 86] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
To investigate the role of neuron-glial cell interactions in the auditory nerve, we asked whether spiral ganglion neurons (SGNs) express neuregulin and whether neuregulin regulates proliferation and/or neurotrophin expression in spiral ganglion Schwann cells (SGSCs). Using immunocytochemistry, we found that type I and type II SGNs express neuregulin in vivo and in vitro. Cultured SGSCs express the neuregulin receptors ErbB2 and ErbB3, but not ErbB4. Neuregulin activates ErbB2 and ErbB3 in cultured SGSCs, evidenced by increased tyrosine phosphorylation of the receptors following neuregulin treatment. Neuregulin treatment increased the proliferation rate of cultured SGSCs by 2.5-fold. Fibroblast growth factor-2 (FGF-2) and transforming growth factor beta (TGF-beta) also increased SGSC proliferation. The mitogenic effect of neuregulin and FGF-2 was blocked by inhibition of mitogen-activated protein kinase signaling but not by inhibition of phosphatidylinositol-3'-OH kinase. Using RT-PCR, we found that cultured SGSCs express neurotrophins, including brain-derived neurotrophic factor and neurotrophin-3 (NT-3), raising the possibility that SGSCs contribute to the trophic support of SGNs. Treatment with neither neuregulin nor TGF-beta increased neurotrophin expression in cultured SGSCs, as had been observed in developing sympathetic ganglia, but appeared to negatively regulate NT-3 expression. Thus, neuregulin and neurotrophins may mediate reciprocal neuron-glial interactions in the auditory nerve.
Collapse
Affiliation(s)
- M R Hansen
- Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, IA 52242, USA
| | | | | | | |
Collapse
|
125
|
Li Q, Loeb JA. Neuregulin-heparan-sulfate proteoglycan interactions produce sustained erbB receptor activation required for the induction of acetylcholine receptors in muscle. J Biol Chem 2001; 276:38068-75. [PMID: 11502740 DOI: 10.1074/jbc.m104485200] [Citation(s) in RCA: 66] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Neuregulins bind to and activate members of the EGF receptor family of tyrosine kinases that initiate a signaling cascade that induces acetylcholine receptor synthesis in the postsynaptic membrane of neuromuscular synapses. In addition to an EGF-like domain, sufficient for receptor binding and tyrosine auto-phosphorylation, many spliced forms also have an IG-like domain that binds HSPGs and maintains a high concentration of neuregulin at synapses. Here, we show that the IG-like domain functions to keep the EGF-like domain at sufficiently high concentrations for a sufficiently long period of time necessary to induce acetylcholine receptor gene expression in primary chick myotubes. Using recombinant neuregulins with and without the IG-like domain, we found that IG-like domain binding to endogenous HSPGs produces a 4-fold increase in receptor phosphorylation. This enhancement of activity was blocked by soluble heparin or by pretreatment of muscle cells with heparitinase. We show that at least 12-24 h of neuregulin exposure was required to turn on substantial acetylcholine receptor gene expression and that the erbB receptors need to be kept phosphorylated during this time. The need for sustained erbB receptor activation may be the reason why neuregulins are so highly concentrated in the extracellular matrix of synapses.
Collapse
Affiliation(s)
- Q Li
- Department of Neurology and the Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan 48201, USA
| | | |
Collapse
|
126
|
Long-term maintenance of channel distribution in a central pattern generator neuron by neuromodulatory inputs revealed by decentralization in organ culture. J Neurosci 2001. [PMID: 11549743 DOI: 10.1523/jneurosci.21-18-07331.2001] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Organotypic cultures of the lobster (Homarus gammarus) stomatogastric nervous system (STNS) were used to assess changes in membrane properties of neurons of the pyloric motor pattern-generating network in the long-term absence of neuromodulatory inputs to the stomatogastric ganglion (STG). Specifically, we investigated decentralization-induced changes in the distribution and density of the transient outward current, I(A), which is encoded within the STG by the shal gene and plays an important role in shaping rhythmic bursting of pyloric neurons. Using an antibody against lobster shal K(+) channels, we found shal immunoreactivity in the membranes of neuritic processes, but not somata, of STG neurons in 5 d cultured STNS with intact modulatory inputs. However, in 5 d decentralized STG, shal immunoreactivity was still seen in primary neurites but was likewise present in a subset of STG somata. Among the neurons displaying this altered shal localization was the pyloric dilator (PD) neuron, which remained rhythmically active in 5 d decentralized STG. Two-electrode voltage clamp was used to compare I(A) in synaptically isolated PD neurons in long-term decentralized STG and nondecentralized controls. Although the voltage dependence and kinetics of I(A) changed little with decentralization, the maximal conductance of I(A) in PD neurons increased by 43.4%. This increase was consistent with the decentralization-induced increase in shal protein expression, indicating an alteration in the density and distribution of functional A-channels. Our results suggest that, in addition to the short-term regulation of network function, modulatory inputs may also play a role, either directly or indirectly, in controlling channel number and distribution, thereby maintaining the biophysical character of neuronal targets on a long-term basis.
Collapse
|
127
|
Zwick M, Teng L, Mu X, Springer JE, Davis BM. Overexpression of GDNF induces and maintains hyperinnervation of muscle fibers and multiple end-plate formation. Exp Neurol 2001; 171:342-50. [PMID: 11573987 DOI: 10.1006/exnr.2001.7753] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
This study examined the role of glial cell line-derived neurotrophic factor (GDNF) in synaptic plasticity at the developing neuromuscular junction. Transgenic mice overexpressing GDNF in skeletal muscle under the myosin light chain-1 promoter were isolated. Northern blot and ELISA at 6 weeks of age indicated that GDNF mRNA and protein levels were elevated threefold in the lateral gastrocnemius muscle (LGM) of the GDNF-transgenic animals. Histochemical examination of LGM tissue sections at 6 weeks of age revealed a 70% increase in the number of cholinesterase-positive end plates without changes in end-plate area. Multiple end plates on a single muscle fiber were also observed, in addition to multiple axonal processes terminating on individual end plates. No change in the number of spinal motoneurons, overall LGM size, or muscle type composition was observed. Finally, overexpression of GDNF in muscle caused hypertrophy of neuronal somata in dorsal root ganglia without affecting their number. These findings demonstrate that overexpression of a single neurotrophic factor in skeletal muscle induces multiple end-plate formation and maintains hyperinnervation well beyond the normal developmental period. We suggest that GDNF, a muscle-derived motoneuron neurotrophic factor, serves an important role in the regulation of synaptic plasticity in the developing and adult neuromuscular junction.
Collapse
Affiliation(s)
- M Zwick
- Department of Anatomy and Neurobiology, University of Kentucky School of Medicine, 800 Rose Street, Lexington, Kentucky 40536-0298, USA
| | | | | | | | | |
Collapse
|
128
|
Park SK, Miller R, Krane I, Vartanian T. The erbB2 gene is required for the development of terminally differentiated spinal cord oligodendrocytes. J Cell Biol 2001; 154:1245-58. [PMID: 11564761 PMCID: PMC2150828 DOI: 10.1083/jcb.200104025] [Citation(s) in RCA: 78] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Development of oligodendrocytes and the generation of myelin internodes within the spinal cord depends on regional signals derived from the notochord and axonally derived signals. Neuregulin 1 (NRG)-1, localized in the floor plate as well as in motor and sensory neurons, is necessary for normal oligodendrocyte development. Oligodendrocytes respond to NRGs by activating members of the erbB receptor tyrosine kinase family. Here, we show that erbB2 is not necessary for the early stages of oligodendrocyte precursor development, but is essential for proligodendroblasts to differentiate into galactosylcerebroside-positive (GalC+) oligodendrocytes. In the presence of erbB2, oligodendrocyte development is normal. In the absence of erbB2 (erbB2-/-), however, oligodendrocyte development is halted at the proligodendroblast stage with a >10-fold reduction in the number of GalC+ oligodendrocytes. ErbB2 appears to function in the transition of proligodendroblast to oligodendrocyte by transducing a terminal differentiation signal, since there is no evidence of increased oligodendrocyte death in the absence of erbB2. Furthermore, known survival signals for oligodendrocytes increase oligodendrocyte numbers in the presence of erbB2, but fail to do so in the absence of erbB2. Of the erbB2-/- oligodendrocytes that do differentiate, all fail to ensheath neurites. These data suggest that erbB2 is required for the terminal differentiation of oligodendrocytes and for development of myelin.
Collapse
Affiliation(s)
- S K Park
- Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA
| | | | | | | |
Collapse
|
129
|
Neuregulins increase alpha7 nicotinic acetylcholine receptors and enhance excitatory synaptic transmission in GABAergic interneurons of the hippocampus. J Neurosci 2001. [PMID: 11466437 DOI: 10.1523/jneurosci.21-15-05660.2001] [Citation(s) in RCA: 98] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Neuregulins are highly expressed in the CNS, especially in cholinergic neurons. We have examined the effect of neuregulin on nicotinic acetylcholine receptors (nAChRs) in neurons dissociated from the rat hippocampus. Rapid application of acetylcholine (ACh) induced a rapidly rising and decaying inward current in some of the neurons, which was completely blocked by methyllycaconitine, a specific antagonist of the alpha7 subunit of the nAChR. When the cells were treated with 5 nm neuregulin (NRG1-beta1) for 2-4 d, a twofold increase in amplitude of the peak ACh-induced current was observed, and there was a comparable increase in (125)I-alpha-bungarotoxin binding. The fast ACh-induced peak current was prominent in large neurons that also contained GABA immunoreactivity. These presumptive GABAergic neurons constituted approximately 10% of neurons present in 7- to 9-d-old cultures. In addition to the large inward peak current, ACh also evoked transmitter release from presynaptic nerve terminals. Pharmacologic experiments indicated that the shower of PSCs was mediated by glutamate, with a small minority caused by the action of GABA. Chronic exposure to NRG1-beta1 increased the amplitude of ACh-evoked PSCs but not the minimum "quantal" PSC. NRG1-beta1 also increased the percentage of neurons that exhibited ACh-evoked PSCs.
Collapse
|
130
|
LoPresti P, Muma NA, De Vries GH. Neu differentiation factor regulates tau protein and mRNA in cultured neonatal oligodendrocytes. Glia 2001; 35:147-55. [PMID: 11460270 DOI: 10.1002/glia.1079] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Axonal signals activate myelinogenesis via regulation of the extent to which oligodendrocyte (OLG) processes wrap around the axon. The cytoskeleton in OLG processes is actively involved in myelination and is a putative target for axonal regulation of myelination. The axon-associated neuregulins may regulate the cytoskeleton extensions in OLG processes. Here, we report that the neuregulin neu differentiation factor (NDF) increases the expression of tau mRNA and tau protein in OLGs. Treatment of neonatal OLGs with alpha-NDF or beta-NDF resulted in dramatic increases in the length of OLG processes, which appeared either as singular unbranched extensions or as a network of extensively branched processes. By immunoblot analysis with tau-1 mAb, which recognizes the dephosphorylated form of the tau proteins, neonatal OLGs treated with alpha-NDF or beta-NDF, had an increase in tau protein levels. The increase of tau levels in beta-NDF-treated cells is much greater than the twofold increase present in alpha-NDF-treated cells. By immunoblot analysis with the phosphorylation-insensitive tau-5 mAb, beta-NDF-treated cells had a twofold increase in tau. Immunoblot analysis suggest that alpha-NDF and beta-NDF promote a twofold increase in the tau protein levels in OLG, with the beta-factor also promoting a tau dephosphorylation. Using promoters spanning the amino-terminal region of tau, we found that OLGs treated with alpha-NDF or beta-NDF contained approximately twofold more tau mRNA than untreated cells. However, there was no qualitative difference between control and NDF-treated cells in the pattern of tau mRNA isoforms expressed. A model is proposed in which the axonal NDF-induced regulation of tau expression in OLGs may be part of the mechanism by which the axon regulates myelination.
Collapse
MESH Headings
- Animals
- Animals, Newborn/anatomy & histology
- Animals, Newborn/growth & development
- Animals, Newborn/metabolism
- Axons/drug effects
- Axons/metabolism
- Axons/ultrastructure
- Cell Differentiation/drug effects
- Cell Differentiation/physiology
- Cells, Cultured/cytology
- Cells, Cultured/drug effects
- Cells, Cultured/metabolism
- Central Nervous System/cytology
- Central Nervous System/growth & development
- Central Nervous System/metabolism
- Fluorescent Antibody Technique
- Gene Expression Regulation/drug effects
- Gene Expression Regulation/physiology
- Myelin Sheath/drug effects
- Myelin Sheath/metabolism
- Myelin Sheath/ultrastructure
- Neuregulin-1/metabolism
- Neuregulin-1/pharmacology
- Oligodendroglia/cytology
- Oligodendroglia/drug effects
- Oligodendroglia/metabolism
- Protein Isoforms/drug effects
- Protein Isoforms/metabolism
- Protein Structure, Tertiary/drug effects
- Protein Structure, Tertiary/physiology
- RNA, Messenger/drug effects
- RNA, Messenger/metabolism
- Rats
- Rats, Sprague-Dawley
- Reverse Transcriptase Polymerase Chain Reaction
- tau Proteins/drug effects
- tau Proteins/genetics
- tau Proteins/metabolism
Collapse
Affiliation(s)
- P LoPresti
- Department of Pathology, Loyola University Medical Center, Maywood, Illinois, USA.
| | | | | |
Collapse
|
131
|
Anson BD, Roberts WM. Sodium channel distribution on uninnervated and innervated embryonic skeletal myotubes. JOURNAL OF NEUROBIOLOGY 2001; 48:42-57. [PMID: 11391648 DOI: 10.1002/neu.1041] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Acetylcholine receptor (AChR) and sodium (Na(+)) channel distributions within the membrane of mature vertebrate skeletal muscle fibers maximize the probability of successful neuromuscular transmission and subsequent action potential propagation. AChRs have been studied intensively as a model for understanding the development and regulation of ion channel distribution within the postsynaptic membrane. Na(+) channel distributions have received less attention, although there is evidence that the temporal accumulation of Na(+) channels at developing neuromuscular junctions (NMJs) may differ between species. Even less is known about the development of extrajunctional Na(+) channel distributions. To further our understanding of Na(+) channel distributions within junctional and extrajunctional membranes, we used a novel voltage-clamp method and fluorescent probes to map Na(+) channels on embryonic chick muscle fibers as they developed in vitro and in vivo. Na(+) current densities on uninnervated myotubes were approximately one-tenth the density found within extrajunctional regions of mature fibers, and showed several-fold variations that could not be explained by a random scattering of single channels. Regions of high current density were not correlated with cellular landmarks such as AChR clusters or myonuclei. Under coculture conditions, AChRs rapidly concentrated at developing synapses, while Na(+) channels did not show a significant increase over the 7 day coculture period. In vivo investigations supported a significant temporal separation between Na(+) channel and AChR aggregation at the developing NMJ. These data suggest that extrajunctional Na(+) channels cluster together in a neuronally independent manner and concentrate at the developing avian NMJ much later than AChRs.
Collapse
Affiliation(s)
- B D Anson
- Department of Medicine, University of Wisconsin-Madison, Rm. 24 SMI, 1300 University Ave, Madison, Wisconsin 53706, USA.
| | | |
Collapse
|
132
|
Sweeney C, Fambrough D, Huard C, Diamonti AJ, Lander ES, Cantley LC, Carraway KL. Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors. J Biol Chem 2001; 276:22685-98. [PMID: 11297548 DOI: 10.1074/jbc.m100602200] [Citation(s) in RCA: 91] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
The mechanisms by which receptor tyrosine kinases (RTKs) utilize intracellular signaling pathways to direct gene expression and cellular response remain unclear. A current question is whether different RTKs within a single cell target similar or different sets of genes. In this study we have used the ErbB receptor network to explore the relationship between RTK activation and gene expression. We profiled growth factor-stimulated signaling pathway usage and broad gene expression patterns in two human mammary tumor cell lines expressing different complements of ErbB receptors. Although the growth factors epidermal growth factor (EGF) and neuregulin (NRG) 1 similarly stimulated Erk1/2 in MDA-MB-361 cells, EGF acting through an EGF receptor/ErbB2 heterodimer preferentially stimulated protein kinase C, and NRG1beta acting through an ErbB2/ErbB3 heterodimer preferentially stimulated Akt. The two growth factors regulated partially overlapping yet distinct sets of genes in these cells. In MDA-MB-453 cells, NRG1beta acting through an ErbB2/ErbB3 heterodimer stimulated prolonged signaling of all pathways examined relative to NRG2beta acting through the same heterodimeric receptor species. Surprisingly, NRG1beta and NRG2beta also regulated partially overlapping but distinct sets of genes in these cells. These results demonstrate that the activation of different RTKs, or activation of the same RTKs with different ligands, can lead to distinct profiles of gene regulation within a single cell type. Our observations also suggest that the identity and kinetics of signaling pathway usage by RTKs may play a role in the selection of regulated genes.
Collapse
Affiliation(s)
- C Sweeney
- Department of Cell Biology, Harvard Medical School and Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.
| | | | | | | | | | | | | |
Collapse
|
133
|
Src, Fyn, and Yes are not required for neuromuscular synapse formation but are necessary for stabilization of agrin-induced clusters of acetylcholine receptors. J Neurosci 2001. [PMID: 11312300 DOI: 10.1523/jneurosci.21-09-03151.2001] [Citation(s) in RCA: 73] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Mice deficient in src and fyn or src and yes move and breathe poorly and die perinatally, consistent with defects in neuromuscular function. Src and Fyn are associated with acetylcholine receptors (AChRs) in muscle cells, and Src and Yes can act downstream of ErbB2, suggesting roles for Src family kinases in signaling pathways regulating neuromuscular synapse formation. We studied neuromuscular synapses in src(-/-); fyn(-/-) and src(-/-); yes(-/-) mutant mice and found that muscle development, motor axon pathfinding, clustering of postsynaptic proteins, and synapse-specific transcription are normal in these double mutants, showing that these pairs of kinases are not required for early steps in synapse formation. We generated muscle cell lines lacking src and fyn and found that neural agrin and laminin-1 induced normal clustering of AChRs and that agrin induced normal tyrosine phosphorylation of the AChR beta subunit in the absence of Src and Fyn. Another Src family member, most likely Yes, was associated with AChRs and phosphorylated by agrin in myotubes lacking Src and Fyn, indicating that Yes may compensate for the loss of Src and Fyn. Nevertheless, PP1 and PP2, inhibitors of Src-class kinases, did not inhibit agrin signaling, suggesting that Src class kinase activity is dispensable for agrin-induced clustering and tyrosine phosphorylation of AChRs. AChR clusters, however, were less stable in myotubes lacking Src and Fyn but not in PP1- or PP2-treated wild-type cells. These data show that the stabilization of agrin-induced AChR clusters requires Src and Fyn and suggest that the adaptor activities, rather than the kinase activities, of these kinases are essential for this stabilization.
Collapse
|
134
|
Abstract
The neuregulins are a complex family of factors that perform many functions during neural development. Recent experiments have shown that neuregulins promote neuronal migration and differentiation, and regulate the selective expression of neurotransmitter receptors in neurons and at the neuromuscular junction. They also regulate glial commitment, proliferation, survival and differentiation. At interneuronal synapses, neuregulin ErbB receptors associate with PDZ-domain proteins at postsynaptic densities where they can modulate synaptic plasticity. How this combinatorial network - comprising many neuregulin ligands that signal through distinct combinations of dimeric ErbB receptors - elicits its multitude of biological effects is beginning to be resolved.
Collapse
Affiliation(s)
- A Buonanno
- Section on Molecular Neurobiology, Building 49, Room 5A-38, National Institutes of Health, Bethesda, Maryland 20892-4480, USA.
| | | |
Collapse
|
135
|
Huang YZ, Wang Q, Xiong WC, Mei L. Erbin is a protein concentrated at postsynaptic membranes that interacts with PSD-95. J Biol Chem 2001; 276:19318-26. [PMID: 11279080 DOI: 10.1074/jbc.m100494200] [Citation(s) in RCA: 79] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Neuregulin is a factor essential for synapse-specific transcription of acetylcholine receptor genes at the neuromuscular junction. Its receptors, ErbB receptor tyrosine kinases, are localized at the postjunctional membrane presumably to ensure localized signaling. However, the molecular mechanisms underlying synaptic localization of ErbBs are unknown. Our recent studies indicate that ErbB4 interacts with postsynaptic density (PSD)-95 (SAP90), a PDZ domain-containing protein that does not interact with ErbB2 or ErbB3. Using as bait the ErbB2 C terminus, we identified Erbin, another PDZ domain-containing protein that interacts specifically with ErbB2. Erbin is concentrated in postsynaptic membranes at the neuromuscular junction and in the central nervous system, where ErbB2 is concentrated. Expression of Erbin increases the amount of ErbB2 labeled by biotin in transfected cells, suggesting that Erbin is able to increase ErbB2 surface expression. Furthermore, we provide evidence that Erbin interacts with PSD-95 in both transfected cells and synaptosomes. Thus ErbB proteins can interact with a network of PDZ domain-containing proteins. This interaction may play an important role in regulation of neuregulin signaling and/or subcellular localization of ErbB proteins.
Collapse
MESH Headings
- Adaptor Proteins, Signal Transducing
- Animals
- Biotin/metabolism
- Blotting, Northern
- Carrier Proteins/chemistry
- Carrier Proteins/genetics
- Cell Line
- Cell Membrane/metabolism
- Cells, Cultured
- Cloning, Molecular
- DNA, Complementary/metabolism
- Disks Large Homolog 4 Protein
- ErbB Receptors/metabolism
- Fungal Proteins/metabolism
- Glutathione Transferase/metabolism
- Hippocampus/metabolism
- Humans
- Immunoblotting
- Immunohistochemistry
- Intracellular Signaling Peptides and Proteins
- Membrane Proteins
- Muscles/embryology
- Muscles/metabolism
- Nerve Tissue Proteins/chemistry
- Nerve Tissue Proteins/metabolism
- Neuromuscular Junction/metabolism
- Precipitin Tests
- Protein Binding
- Protein Structure, Tertiary
- RNA, Messenger/metabolism
- Rats
- Receptor, ErbB-2/metabolism
- Receptor, ErbB-3/metabolism
- Receptor, ErbB-4
- Signal Transduction
- Subcellular Fractions
- Tissue Distribution
- Transcription, Genetic
- Transfection
- Two-Hybrid System Techniques
Collapse
Affiliation(s)
- Y Z Huang
- Departments of Neurobiology, University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama 35294, USA
| | | | | | | |
Collapse
|
136
|
Gaspersic R, Koritnik B, Erzen I, Sketelj J. Muscle activity-resistant acetylcholine receptor accumulation is induced in places of former motor endplates in ectopically innervated regenerating rat muscles. Int J Dev Neurosci 2001; 19:339-46. [PMID: 11337203 DOI: 10.1016/s0736-5748(01)00018-1] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Expression of acetylcholine receptors (AChRs) in the extrajunctional muscle regions, but not in the neuromuscular junctions, is repressed by propagated electric activity in muscle fibers. During regeneration, subsynaptic-like specializations accumulating AChRs are induced in new myotubes by agrin attached to the synaptic basal lamina at the places of former motor endplates even in the absence of innervation. We examined whether AChRs still accumulated at these places when the regenerating muscles were ectopically innervated and the former synaptic places became extrajunctional. Rat soleus muscles were injured by bupivacaine and ischemia to produce complete myofiber degeneration. The soleus muscle nerve was permanently severed and the muscle was ectopically innervated by the peroneal nerve a few millimeters away from the former junctional region. After 4 weeks of regeneration, the muscles contracted upon nerve stimulation, showed little atrophy and the cross-section areas of their fibers were completely above the range in non-innervated regenerating muscles, indicating successful innervation. Subsynaptic-like specializations in the former junctional region still accumulated AChRs (and acetylcholinesterase) although no motor nerve endings were observed in their vicinity and the cross-section area of their fibers clearly demonstrated that they were ectopically innervated. We conclude that the expression of AChRs at the places of the former neuromuscular junctions in the ectopically innervated regenerated soleus muscles is activity-independent.
Collapse
Affiliation(s)
- R Gaspersic
- Institute of Pathophysiology, School of Medicine, University of Ljubljana, Zaloska 4, 1000, Ljubljana, Slovenia
| | | | | | | |
Collapse
|
137
|
Suárez E, Bach D, Cadefau J, Palacin M, Zorzano A, Gumá A. A novel role of neuregulin in skeletal muscle. Neuregulin stimulates glucose uptake, glucose transporter translocation, and transporter expression in muscle cells. J Biol Chem 2001; 276:18257-64. [PMID: 11278386 DOI: 10.1074/jbc.m008100200] [Citation(s) in RCA: 84] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Neuregulins regulate the expression of acetylcholine receptor genes and induce development of the neuromuscular junction in muscle. In studying whether neuregulins regulate glucose uptake in muscle, we analyzed the effect of a recombinant neuregulin, (r)heregulin-beta1-(177-244) (HRG), on L6E9 muscle cells, which express the neuregulin receptors ErbB2 and ErbB3. L6E9 responded acutely to HRG by a time- and concentration-dependent stimulation of 2-deoxyglucose uptake. HRG-induced stimulation of glucose transport was additive to the effect of insulin. The acute stimulation of the glucose transport induced by HRG was a consequence of the translocation of GLUT4, GLUT1, and GLUT3 glucose carriers to the cell surface. The effect of HRG on glucose transport was dependent on phosphatidylinositol 3-kinase activity. HRG also stimulated glucose transport in the incubated soleus muscle and was additive to the effect of insulin. Chronic exposure of L6E9 cells to HRG potentiated myogenic differentiation, and under these conditions, glucose transport was also stimulated. The activation of glucose transport after chronic HRG exposure was due to enhanced cell content of GLUT1 and GLUT3 and to increased abundance of these carriers at the plasma membrane. However, under these conditions, GLUT4 expression was markedly down-regulated. Muscle denervation is associated with GLUT1 induction and GLUT4 repression. In this connection, muscle denervation caused a marked increase in the content of ErbB2 and ErbB3 receptors, which occurred in the absence of alterations in neuregulin mRNA levels. This fact suggests that neuregulins regulate glucose transporter expression in denervated muscle. We conclude that neuregulins regulate glucose uptake in L6E9 muscle cells by mechanisms involving the recruitment of glucose transporters to the cell surface and modulation of their expression. Neuregulins may also participate in the adaptations in glucose transport that take place in the muscle fiber after denervation.
Collapse
Affiliation(s)
- E Suárez
- Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Facultat de Medicina, Universitat de Barcelona, E-08028 Barcelona, Spain
| | | | | | | | | | | |
Collapse
|
138
|
Buffelli M, Pasino E, Cangiano A. In vivo acetylcholine receptor expression induced by calcitonin gene-related peptide in rat soleus muscle. Neuroscience 2001; 104:561-7. [PMID: 11377855 DOI: 10.1016/s0306-4522(01)00090-2] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
We applied calcitonin gene-related peptide (CGRP) by continuous perfusion of the extrajunctional surface of the adult rat soleus muscle in vivo. We obtained this through a fine polyethylene catheter connected to an Alzet pump implanted in the animal. The perfusion induced a local acetylcholine receptor accumulation in the membrane of the muscle fibres starting with a delay of one to two days, provided a chronic conduction block of soleus innervation was concomitantly present. The effect was prominent, being higher than that following denervation. The lack of acetylcholine receptor accumulation observed in sham perfused animals and the co-administration of CGRP and its competitive antagonist peptide, hCGRP(8-37), eliminates the possibility that the response to CGRP application represents an inflammatory reaction to foreign bodies instead of a specific effect of the peptide. We suggest that CGRP may act on the extrajunctional membrane of muscle fibres to help induce acetylcholine receptor accumulation after appropriate receptors for the peptide are re-expressed due to muscle paralysis. Whilst this is compatible with a role of CGRP in synaptogenesis, a recent study showed that alpha-CGRP(-/-) mutant mice have normal neuromuscular junction development. However, given the redundancy of factors involved in acetylcholine receptor accumulation, further experiments on multiple knock-outs need to be performed before a final conclusion is reached about the physiological significance of CGRP.
Collapse
MESH Headings
- Animals
- Calcitonin Gene-Related Peptide/metabolism
- Calcitonin Gene-Related Peptide/pharmacology
- Cell Differentiation/drug effects
- Cell Differentiation/physiology
- Dose-Response Relationship, Drug
- Male
- Membrane Potentials/drug effects
- Membrane Potentials/physiology
- Miotics/pharmacology
- Motor Neurons/cytology
- Motor Neurons/drug effects
- Motor Neurons/metabolism
- Muscle Contraction/drug effects
- Muscle Contraction/physiology
- Muscle Development
- Muscle Fibers, Skeletal/cytology
- Muscle Fibers, Skeletal/drug effects
- Muscle Fibers, Skeletal/metabolism
- Muscle, Skeletal/drug effects
- Muscle, Skeletal/growth & development
- Muscle, Skeletal/innervation
- Neuromuscular Junction/cytology
- Neuromuscular Junction/drug effects
- Neuromuscular Junction/metabolism
- Neuronal Plasticity/drug effects
- Neuronal Plasticity/physiology
- Peptide Fragments/pharmacology
- Rats
- Rats, Wistar
- Receptors, Cholinergic/drug effects
- Receptors, Cholinergic/metabolism
- Sodium Channels/drug effects
- Sodium Channels/metabolism
Collapse
Affiliation(s)
- M Buffelli
- Dipartimento di Scienze Neurologiche e della Visione, Sezione di Fisiologia, Università di Verona, Strada Le Grazie 8, 37134, Verona, Italy
| | | | | |
Collapse
|
139
|
Yang X, Arber S, William C, Li L, Tanabe Y, Jessell TM, Birchmeier C, Burden SJ. Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. Neuron 2001; 30:399-410. [PMID: 11395002 DOI: 10.1016/s0896-6273(01)00287-2] [Citation(s) in RCA: 361] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The patterning of skeletal muscle is thought to depend upon signals provided by motor neurons. We show that AChR gene expression and AChR clusters are concentrated in the central region of embryonic skeletal muscle in the absence of innervation. Neurally derived Agrin is dispensable for this early phase of AChR expression, but MuSK, a receptor tyrosine kinase activated by Agrin, is required to establish this AChR prepattern. The zone of AChR expression in muscle lacking motor axons is wider than normal, indicating that neural signals refine this muscle-autonomous prepattern. Neuronal Neuregulin-1, however, is not involved in this refinement process, nor indeed in synapse-specific AChR gene expression. Our results demonstrate that AChR expression is patterned in the absence of innervation, raising the possibility that similarly prepatterned muscle-derived cues restrict axon growth and initiate synapse formation.
Collapse
MESH Headings
- Agrin/deficiency
- Agrin/genetics
- Agrin/metabolism
- Animals
- Axons/physiology
- Body Patterning/physiology
- Embryonic and Fetal Development
- Gene Expression Regulation, Developmental
- Mice
- Mice, Knockout
- Motor Neurons/physiology
- Muscle Denervation
- Muscle, Skeletal/embryology
- Muscle, Skeletal/innervation
- Neuregulins/genetics
- Neuregulins/physiology
- Neurons, Afferent/physiology
- Receptor Protein-Tyrosine Kinases/deficiency
- Receptor Protein-Tyrosine Kinases/genetics
- Receptor Protein-Tyrosine Kinases/metabolism
- Receptors, Cell Surface/genetics
- Receptors, Cell Surface/physiology
- Receptors, Cholinergic/genetics
- Receptors, G-Protein-Coupled
- Receptors, Lysophospholipid
- Recombination, Genetic
- Synapses/physiology
Collapse
Affiliation(s)
- X Yang
- Molecular Neurobiology Program, Skirball Institute, New York University Medical School, New York, NY 10011, USA
| | | | | | | | | | | | | | | |
Collapse
|
140
|
Fromm L, Burden SJ. Neuregulin-1-stimulated phosphorylation of GABP in skeletal muscle cells. Biochemistry 2001; 40:5306-12. [PMID: 11318655 DOI: 10.1021/bi002649m] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
Localization of acetylcholine receptors (AChRs) to neuromuscular synapses is mediated, in part, through selective transcription of AChR genes in myofiber synaptic nuclei. Neuregulin-1 (NRG-1) is a good candidate for the extracellular signal that induces synapse-specific gene expression, since NRG-1 is concentrated at synaptic sites and activates AChR synthesis in cultured muscle cells. NRG-1-induced transcription requires activation of Erk and Jnk MAP kinases, but the downstream substrates that mediate this transcriptional response are not known. Previous studies have demonstrated that a consensus binding site for Ets proteins is required both for NRG-1-induced transcription and for synapse-specific transcription in transgenic mice. This regulatory element binds GABPalpha, an Ets protein, and GABPbeta, a protein that dimerizes with GABPalpha, raising the possibility that phosphorylation of GABP by MAP kinases induces transcription of AChR genes. To determine whether MAP kinases might directly regulate the activity of GABP, we studied MAP kinase-catalyzed and NRG-1-induced phosphorylation of GABPalpha and GABPbeta. We show that GABPalpha and GABPbeta are phosphorylated in vitro by Erk and by Jnk. Using recombinant proteins containing mutated serine and threonine resides, we show that GABPalpha is phosphorylated predominantly at threonine 280, while serine 170 and threonine 180 are the major phosphorylation sites in GABPbeta. We generated antibodies specific to the major phosphorylation site in GABPalpha and show that NRG-1 stimulates phosphorylation of GABPalpha at threonine 280 in vivo. These results suggest that GABPalpha is a target of MAP kinases in NRG-1-stimulated muscle cells and are consistent with the idea that phosphorylation of GABPalpha contributes to transcriptional activation of AChR genes by NRG-1.
Collapse
Affiliation(s)
- L Fromm
- Molecular Neurobiology Program, Skirball Institute of Biomolecular Medicine, NYU Medical School, New York, NY 10016, USA
| | | |
Collapse
|
141
|
Choi RC, Siow NL, Zhu SQ, Wan DC, Wong YH, Tsim KW. The cyclic AMP-mediated expression of acetylcholinesterase in myotubes shows contrasting activation and repression between avian and mammalian enzymes. Mol Cell Neurosci 2001; 17:732-45. [PMID: 11312608 DOI: 10.1006/mcne.2001.0968] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Cyclic adenosine 3',5'-monophosphate (cAMP)-dependent signalling pathway has been proposed to regulate acetylcholinesterase (AChE) expression in chick muscle; however, its role in mammalian enzyme is not known. We provide several lines of evidence to suggest that the cAMP-mediated AChE expression in myotube is oppositely regulated between avian and mammalian enzymes. Human AChE promoter was tagged with luciferase, namely Hp-Luc, which was transfected into cultured chick myotubes. Application of cAMP and forskolin induced the expression of chick AChE but reduced human AChE promoter-driven luciferase activity. Transfection of cDNAs encoding active mutants of G proteins altered the intracellular cAMP level in myotubes as well as the expression of chick and human AChE. When the constitutively active forms of Activating Transcription Factor-1 (EWS/ATF-1 oncogene) were over expressed in Hp-Luc transfected myotubes, the expression of chick AChE transcript and protein increased from approximately 1.8- to approximately 2.5-fold, but the luciferase activity was decreased by over 60%. Overexpression of cAMP-responsive element binding protein (CREB) in Hp-Luc transfected myotubes markedly enhanced the cAMP-mediated AChE expression in up- and downregulated chick and human enzymes, respectively. In addition, CREB bound the CRE sequence of human AChE promoter. Mutation on the CRE site markedly enhanced the expression of the promoter-driven luciferase; however, its response to cAMP inhibition in cultured myotubes was still retained. These findings suggest that a cAMP-dependent pathway is contrasting activation and repression of AChE expression in chick and human muscles.
Collapse
Affiliation(s)
- R C Choi
- Department of Biology, Department of Biochemistry, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay Road, Hong Kong, China
| | | | | | | | | | | |
Collapse
|
142
|
Abstract
In developing and mature neural circuits, neural electrical activity controls the correct formation of connections and their state. Neuregulins (NRGs) mediate between the electrical neural activity and molecular components by regulating the expression of ion channel receptors or transmitter release in synapses. Furthermore, NRGs may be signaling factors involved in tuning locomotion or other higher functions by coordinating excitatory and inhibitory neurons.
Collapse
Affiliation(s)
- M Ozaki
- Laboratory for Cellular Information Processing, Brain Science Institute, The Institute of Physical and Chemical Research, RIKEN, Wako-shi, Saitama, Japan.
| |
Collapse
|
143
|
Fu AK, Fu WY, Cheung J, Tsim KW, Ip FC, Wang JH, Ip NY. Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat Neurosci 2001; 4:374-81. [PMID: 11276227 DOI: 10.1038/86019] [Citation(s) in RCA: 133] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Here we describe an important involvement of Cdk5/p35 in regulating the gene expression of acetylcholine receptor (AChR) at the neuromuscular synapse. Cdk5 and p35 were prominently expressed in embryonic muscle, and concentrated at the neuromuscular junction in adulthood. Neuregulin increased the p35-associated Cdk5 kinase activity in the membrane fraction of cultured C2C12 myotubes. Co-immunoprecipitation studies revealed the association between Cdk5, p35 and ErbB receptors in muscle and cultured myotubes. Inhibition of Cdk5 activity not only blocked the NRG-induced AChR transcription, but also attenuated ErbB activation in cultured myotubes. In light of our finding that overexpression of p35 alone led to an increase in AChR promoter activity in muscle, Cdk5 activation is sufficient to mediate the up-regulation of AChR gene expression. Taken together, these results reveal the unexpected involvement of Cdk5/p35 in neuregulin signaling at the neuromuscular synapse.
Collapse
Affiliation(s)
- A K Fu
- Department of Biochemistry, Biotechnology Research Institute, Molecular Neuroscience Center, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China
| | | | | | | | | | | | | |
Collapse
|
144
|
Ip FC, Cheung J, Ip NY. The expression profiles of neurotrophins and their receptors in rat and chicken tissues during development. Neurosci Lett 2001; 301:107-10. [PMID: 11248434 DOI: 10.1016/s0304-3940(01)01603-2] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Neurotrophic factors are target-derived proteins that promote the survival and differentiation of the innervating neurons. Increasing evidence indicate the involvement of these factors and receptors during the formation and maturation of the neuromuscular junction. To gain further insight on the expression pattern of these factors and receptors in developing spinal cord and skeletal muscle during the critical stages of synapse formation, a systematic study was performed with chicken and rat tissues using Northern blot analysis. The expression of all the neurotrophins was detected in skeletal muscle early in development, coincidental with the appearance of their corresponding receptors in the spinal cord. Taken together, the similar regulatory patterns observed in both rat and chicken tissues suggest that the potential roles of neurotrophins at the neuromuscular synapse are conserved throughout evolution.
Collapse
Affiliation(s)
- F C Ip
- Department of Biochemistry and Biotechnology Research Institute, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, PR China
| | | | | |
Collapse
|
145
|
Schumacher S, Jung M, Nörenberg U, Dorner A, Chiquet-Ehrismann R, Stuermer CA, Rathjen FG. CALEB binds via its acidic stretch to the fibrinogen-like domain of tenascin-C or tenascin-R and its expression is dynamically regulated after optic nerve lesion. J Biol Chem 2001; 276:7337-45. [PMID: 11069908 DOI: 10.1074/jbc.m007234200] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Recently, we described a novel chick neural transmembrane glycoprotein, which interacts with the extracellular matrix proteins tenascin-C and tenascin-R. This protein, termed CALEB, contains an epidermal growth factor-like domain and appears to be a novel member of the epidermal growth factor family of growth and differentiation factors. Here we analyze the interaction between CALEB and tenascin-C as well as tenascin-R in more detail, and we demonstrate that the central acidic peptide segment of CALEB is necessary to mediate this binding. The fibrinogen-like globe within tenascin-C or -R enables both proteins to bind to CALEB. We show that two isoforms of CALEB in chick and rodents exist that differed in their cytoplasmic segments. To begin to understand the in vivo function of CALEB and since in vitro antibody perturbation experiments indicated that CALEB might be important for neurite formation, we analyzed the expression pattern of the rat homolog of CALEB during development of retinal ganglion cells, after optic nerve lesion and during graft-assisted retinal ganglion cell axon regeneration by in situ hybridization. These investigations demonstrate that CALEB mRNA is dynamically regulated after optic nerve lesion and that this mRNA is expressed in most developing and in one-third of the few regenerating (GAP-43 expressing) retinal ganglion cells.
Collapse
Affiliation(s)
- S Schumacher
- Max-Delbrück-Centrum für Molekulare Medizin, Robert-Rössle-Strasse 10, D-13092 Berlin, Germany.
| | | | | | | | | | | | | |
Collapse
|
146
|
Krag TO, Gyrd-Hansen M, Khurana TS. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy. ACTA PHYSIOLOGICA SCANDINAVICA 2001; 171:349-58. [PMID: 11412148 DOI: 10.1046/j.1365-201x.2001.00838.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Duchenne's muscular dystrophy (DMD) is a fatal disease caused by mutations in the DMD gene that lead to quantitative and qualitative disturbances in dystrophin expression. Dystrophin is a member of the spectrin superfamily of proteins. Dystrophin itself is closely related to three proteins that constitute a family of dystrophin-related proteins (DRPs): the chromosome 6-encoded DRP or utrophin, the chromosome-X encoded, DRP2 and the chromosome-18 encoded, dystrobrevin. These proteins share sequence similarity and functional motifs with dystrophin. Current attempts at somatic gene therapy of DMD face numerous technical problems. An alternative strategy for DMD therapy, that circumvents many of these problems, has arisen from the demonstration that the DRP utrophin can functionally substitute for the missing dystrophin and its overexpression can rescue dystrophin-deficient muscle. Currently, a promising avenue of research consists of identifying molecules that would increase the expression of utrophin and the delivery of these molecules to dystrophin-deficient tissues as a means of DMD therapy. In this review, we will focus on DRPs from the perspective of strategies and issues related to upregulating utrophin expression for DMD therapy. Additionally, we will address the techniques used for anatomical, biochemical and physiological evaluation of the potential benefits of this and other forms of DMD therapy in dystrophin-deficient animal models.
Collapse
Affiliation(s)
- T O Krag
- Department of Clinical Biochemistry, Glostrup Hospital, Glostrup, Denmark
| | | | | |
Collapse
|
147
|
Cameron JS, Dryer L, Dryer SE. beta -Neuregulin-1 is required for the in vivo development of functional Ca2+-activated K+ channels in parasympathetic neurons. Proc Natl Acad Sci U S A 2001; 98:2832-6. [PMID: 11226326 PMCID: PMC30225 DOI: 10.1073/pnas.041394098] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2000] [Indexed: 11/18/2022] Open
Abstract
The development of functional Ca(2+)-activated K(+) channels (K(Ca)) in chick ciliary ganglion (CG) neurons requires interactions with afferent preganglionic nerve terminals. Here we show that the essential preganglionic differentiation factor is an isoform of beta-neuregulin-1. beta-Neuregulin-1 transcripts are expressed in the midbrain preganglionic Edinger-Westphal nucleus at developmental stages that coincide with or precede the normal onset of macroscopic K(Ca) in CG neurons. Injection of beta-neuregulin-1 peptide into the brains of developing embryos evoked a robust stimulation of functional K(Ca) channels at stages before the normal appearance of these channels in CG neurons developing in vivo. Conversely, injection of a neutralizing antiserum specific for beta-neuregulin-1 inhibited the development of K(Ca) channels in CG neurons. Low concentrations of beta-neuregulin-1 evoked a robust increase in whole-cell K(Ca) in CG neurons cocultured with iris target tissues. By contrast, culturing CG neurons with iris cells or low concentrations of beta-neuregulin-1 by themselves was insufficient to stimulate K(Ca). These data suggest that the preganglionic factor required for the development of K(Ca) in ciliary ganglion neurons is an isoform of beta-neuregulin-1, and that this factor acts in concert with target-derived trophic molecules to regulate the differentiation of excitability.
Collapse
Affiliation(s)
- J S Cameron
- Department of Biology and Biochemistry, University of Houston, Houston, TX 77204-5513, USA
| | | | | |
Collapse
|
148
|
The Agrin/MuSK signaling pathway is spatially segregated from the neuregulin/ErbB receptor signaling pathway at the neuromuscular junction. J Neurosci 2001. [PMID: 11102484 DOI: 10.1523/jneurosci.20-23-08762.2000] [Citation(s) in RCA: 80] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
The neuregulin/erbB receptor and agrin/MuSK pathways are critical for communication between the nerve, muscle, and Schwann cell that establishes the precise topological arrangement at the vertebrate neuromuscular junction (NMJ). ErbB2, erbB3, and erbB4 as well as neuregulin, agrin, and MuSK are known to be concentrated at the NMJ. Here we have examined NMJs from gastrocnemius muscle of adult rat using immunofluorescence confocal microscopy to characterize in detail the distribution of these proteins relative to the distribution of acetylcholine receptors (AChRs). We have determined that erbB2 and erbB4 are enriched in the depths of the secondary junctional folds on the postsynaptic muscle membrane. In contrast, erbB3 at the NMJ was concentrated at presynaptic terminal Schwann cells. This distribution strongly argues that erbB2/erbB4 heterodimers are the functional postsynaptic neuregulin receptors of the NMJ. Neuregulin was localized to the axon terminal, secondary folds, and terminal Schwann cells, where it was in a position to signal through erbB receptors. MuSK was concentrated in the postsynaptic primary gutter region where it was codistributed with AChRs. Agrin was present at the axon terminal and in the basal lamina associated with the primary gutter region, but not in the secondary junctional folds. The differential distributions of the neuregulin and agrin signaling pathways argue against neuregulin and erbB receptors being localized to the NMJ via direct interactions with either agrin or MuSK.
Collapse
|
149
|
|
150
|
Abstract
When epidermal growth factor and its relatives bind the ErbB family of receptors, they trigger a rich network of signalling pathways, culminating in responses ranging from cell division to death, motility to adhesion. The network is often dysregulated in cancer and lends credence to the mantra that molecular understanding yields clinical benefit: over 25,000 women with breast cancer have now been treated with trastuzumab (Herceptin), a recombinant antibody designed to block the receptor ErbB2. Likewise, small-molecule enzyme inhibitors and monoclonal antibodies to ErbB1 are in advanced phases of clinical testing. What can this pathway teach us about translating basic science into clinical use?
Collapse
Affiliation(s)
- Y Yarden
- Department of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
| | | |
Collapse
|